These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 26351953)

  • 1. Susceptibility of commonly used ferritin assays to the classic hook effect.
    Ranjitkar P; Turtle CJ; Harris NS; Holmes DT; Pyle-Eilola A; Maloney DG; Greene DN
    Clin Chem Lab Med; 2016 Feb; 54(2):e41-3. PubMed ID: 26351953
    [No Abstract]   [Full Text] [Related]  

  • 2. T-cell therapy targets glioblastoma.
    Cancer Discov; 2015 May; 5(5):458. PubMed ID: 25783861
    [No Abstract]   [Full Text] [Related]  

  • 3. [Incidence and elimination of false-negative results of ferritin determination].
    Papik K; Molnár B; Fedorcsák P; Rainer S; Fridl L; Fehér J; Tulassay Z
    Orv Hetil; 1998 Jun; 139(26):1581-4. PubMed ID: 9676120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine-tuning the effects of T-cell therapy.
    Cancer Discov; 2014 Feb; 4(2):137. PubMed ID: 24501286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum ferritin measurement and the degree of agreement using four techniques.
    Stacy DL; Han P
    Am J Clin Pathol; 1992 Nov; 98(5):511-5. PubMed ID: 1485604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic engineering of T cells in leukemia and lymphoma.
    Kochenderfer JN
    Clin Adv Hematol Oncol; 2014 Mar; 12(3):190-2. PubMed ID: 24927269
    [No Abstract]   [Full Text] [Related]  

  • 7. Could standard ISO 15189 be useful for the conundrum of CA 19-9/GI Monitor measurement?
    Dorizzi RM; Meneghelli S; Rocca M; Ferrari A
    Clin Chem Lab Med; 2007; 45(7):928-9. PubMed ID: 17617041
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer-killing CAR therapies gain speed.
    Weber M
    Cancer Discov; 2015 Jan; 5(1):7. PubMed ID: 25583785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition.
    Houot R; Schultz LM; Marabelle A; Kohrt H
    Cancer Immunol Res; 2015 Oct; 3(10):1115-22. PubMed ID: 26438444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in novel cellular therapy options for chronic lymphocytic leukemia: the M D Anderson perspective.
    Shah N; Rezvani K; Hosing C; Kebriaei P; Wierda W; Cooper L; Shpall E
    Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl(Suppl):S18-22. PubMed ID: 25486950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated prozone effect detection in ferritin homogeneous immunoassays using neural network classifiers.
    Papik K; Molnar B; Fedorcsak P; Schaefer R; Lang F; Sreter L; Feher J; Tulassay Z
    Clin Chem Lab Med; 1999 Apr; 37(4):471-6. PubMed ID: 10369120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Of chimeric antigen receptors and antibodies: OX40 and 41BB costimulation sharpen up T cell-based immunotherapy of cancer.
    Hombach AA; Abken H
    Immunotherapy; 2013 Jul; 5(7):677-81. PubMed ID: 23829616
    [No Abstract]   [Full Text] [Related]  

  • 13. Helping CAR T cells reach tumors.
    Cancer Discov; 2015 Jan; 5(1):OF6. PubMed ID: 25583818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro comparison of three different chimeric receptor-modified effector T-cell populations for leukemia cell therapy.
    Pizzitola I; Agostoni V; Cribioli E; Pule M; Rousseau R; Finney H; Lawson A; Biondi A; Biagi E; Marin V
    J Immunother; 2011; 34(6):469-79. PubMed ID: 21654519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical investigation on serum ferritin in patients with leukemia.
    Kageyama T; Tsumoto S; Dohi T; Matsumoto K; Oyabu H
    Bull Osaka Med Sch; 1983 Jul; 29(1):27-35. PubMed ID: 6678165
    [No Abstract]   [Full Text] [Related]  

  • 16. Chimeric antigen receptor T cells: power tools to wipe out leukemia and lymphoma.
    Riet T; Abken H
    Expert Rev Hematol; 2015 Aug; 8(4):383-5. PubMed ID: 25946901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of recalibration of the hs-TnT assay on diagnostic performance.
    Parsonage WA; Tate JR; Greenslade JH; Hammett CJ; Ungerer JP; Pretorius CJ; Brown AF; Cullen L
    Clin Chem Lab Med; 2014 Feb; 52(2):e25-7. PubMed ID: 23924523
    [No Abstract]   [Full Text] [Related]  

  • 18. [Leukemia and serum ferritin (author's transl)].
    Umemura T; Kozuru M
    Rinsho Ketsueki; 1980 Aug; 21(8):1127-34. PubMed ID: 6934323
    [No Abstract]   [Full Text] [Related]  

  • 19. Chimeric T cells for adoptive immunotherapy of cancer: using what have we learned to plan for the future.
    Peinert S; Kershaw MH; Prince HM
    Immunotherapy; 2009 Nov; 1(6):905-12. PubMed ID: 20635906
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum ferritin levels in hematologic malignant neoplasms.
    Patel AR; Shah PC; Vohra RM; Hart WL; Shah JR
    Arch Pathol Lab Med; 1980 Oct; 104(10):509-12. PubMed ID: 6932189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.